Celldex Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Celldex Therapeutics, Inc. (CLDX) reported Basic Shares Outstanding (Weighted Average) of 77.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 77.84M shares, a 17.24% increase year-over-year.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 66.57M shares, a 0.28% increase year-over-year.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 265.49M shares, a 3.15% increase year-over-year.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 66.42K shares, a 0.19% increase year-over-year.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 66.42M shares, a 3.15% increase from fiscal 2024.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 64.39M shares, a 32.91% increase from fiscal 2023.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 48.45M shares, a 103229.21% increase from fiscal 2022.
- Celldex Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 46.89K shares, a 9.37% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 77.84M shares 10-Q · filed 2026-08-06 | 72.23M shares 10-Q · filed 2026-08-06 | 136.63M shares derived: average of 3 quarters · filed 2026-08-06 | 102.49M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 66.57M shares 10-Q · filed 2026-05-07 | 166.03M shares derived: average of 2 quarters · filed 2026-05-07 | 110.71M shares derived: average of 3 quarters · filed 2026-05-07 | 99.63M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 265.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 132.78M shares derived: average of 2 quarters · filed 2026-02-25 | 110.65M shares derived: average of 3 quarters · filed 2026-08-06 | 66.42M shares 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | 66.42K shares 10-Q · filed 2025-11-10 | 33.23M shares derived: average of 2 quarters · filed 2026-08-06 | 66.40K shares 10-Q · filed 2025-11-10 | 97.56M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 66.39M shares 10-Q · filed 2026-08-06 | 66.39K shares 10-Q · filed 2025-08-07 | 66.39M shares 10-Q · filed 2026-08-06 | 66.39K shares 10-Q · filed 2025-08-07 | 130.05M shares derived: average of 3 quarters · filed 2026-08-06 | 97.56M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 66.38M shares 10-Q · filed 2026-05-07 | 66.38K shares 10-Q · filed 2025-05-08 | 161.89M shares derived: average of 2 quarters · filed 2026-05-07 | 107.95M shares derived: average of 3 quarters · filed 2026-05-07 | 80.98M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 257.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 128.73M shares derived: average of 2 quarters · filed 2026-02-25 | 85.84M shares derived: average of 3 quarters · filed 2026-02-25 | 64.39M shares 10-K · filed 2026-02-25 | 64.39K shares 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 66.29K shares 10-Q · filed 2025-11-10 | 66.16K shares derived: average of 2 quarters · filed 2025-11-10 | 63.74K shares 10-Q · filed 2025-11-10 | 48.46M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | 66.02K shares 10-Q · filed 2025-08-07 | 62.45K shares 10-Q · filed 2025-08-07 | 64.59M shares derived: average of 3 quarters · filed 2026-02-25 | 48.46M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | 58.87K shares 10-Q · filed 2025-05-08 | 96.86M shares derived: average of 2 quarters · filed 2026-02-25 | 64.59M shares derived: average of 3 quarters · filed 2026-02-25 | 48.45M shares derived: average of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | 193.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 96.85M shares derived: average of 2 quarters · filed 2026-02-25 | 64.58M shares derived: average of 3 quarters · filed 2026-02-25 | 48.45M shares 10-K · filed 2026-02-25 | 48.45K shares 10-K · filed 2024-02-26 | |||
| 2023-09-30 | 47.26K shares 10-Q · filed 2024-11-06 | 47.26K shares derived: average of 2 quarters · filed 2024-11-06 | 47.24K shares 10-Q · filed 2024-11-06 | 47.22K shares derived: average of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | 47.25K shares 10-Q · filed 2024-08-08 | 47.23K shares 10-Q · filed 2024-08-08 | 47.20K shares derived: average of 3 quarters · filed 2025-02-27 | 47.13K shares derived: average of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | 47.21K shares 10-Q · filed 2024-05-06 | 47.17K shares derived: average of 2 quarters · filed 2025-02-27 | 47.09K shares derived: average of 3 quarters · filed 2025-02-27 | 47.01K shares derived: average of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | 47.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 47.02K shares derived: average of 2 quarters · filed 2025-02-27 | 46.94K shares derived: average of 3 quarters · filed 2025-02-27 | 46.89K shares 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | 46.92K shares 10-Q · filed 2023-11-02 | 46.92M shares 10-Q · filed 2022-11-09 | 46.84K shares derived: average of 2 quarters · filed 2023-11-02 | 46.81K shares 10-Q · filed 2023-11-02 | 46.81M shares 10-Q · filed 2022-11-09 | -31.11M shares derived: average of 4 quarters · filed 2024-02-26 | ||
| 2022-06-30 | 46.76K shares 10-Q · filed 2023-08-08 | 46.76M shares 10-Q · filed 2022-08-08 | 46.75K shares 10-Q · filed 2023-08-08 | 46.75M shares 10-Q · filed 2022-08-08 | -41.49M shares derived: average of 3 quarters · filed 2024-02-26 | -19.76M shares derived: average of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | 46.74K shares 10-Q · filed 2023-05-04 | 46.74M shares 10-Q · filed 2022-05-05 | -62.26M shares derived: average of 2 quarters · filed 2024-02-26 | -26.36M shares derived: average of 3 quarters · filed 2024-02-26 | -9.86M shares derived: average of 4 quarters · filed 2024-02-26 | |||
| 2021-12-31 | -124.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -39.56M shares derived: average of 2 quarters · filed 2024-02-26 | -13.17M shares derived: average of 3 quarters · filed 2024-02-26 | 42.87K shares 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | 45.45M shares 10-Q · filed 2022-11-09 | 42.53M shares derived: average of 2 quarters · filed 2022-11-09 | 41.58M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 39.62M shares 10-Q · filed 2022-08-08 | 39.62M shares 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | 39.61M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 29.64K shares 10-K · filed 2023-02-28 | |||||||
| 2019-12-31 | 14.51K shares 10-K · filed 2022-02-28 | |||||||
| 2012-03-31 | 50.15M shares 10-Q · filed 2012-05-04 | 47.19M shares derived: average of 2 quarters · filed 2012-05-04 | 46.17M shares derived: average of 3 quarters · filed 2012-05-04 | 43.99M shares derived: average of 4 quarters · filed 2012-05-04 | ||||
| 2011-12-31 | 44.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | 44.18M shares derived: average of 2 quarters · filed 2012-03-08 | 41.94M shares derived: average of 3 quarters · filed 2012-03-08 | 39.50M shares 10-K · filed 2012-03-08 | ||||
| 2011-09-30 | 44.14M shares 10-Q · filed 2011-11-03 | 40.80M shares derived: average of 2 quarters · filed 2011-11-03 | 37.93M shares 10-Q · filed 2011-11-03 | 36.42M shares derived: average of 4 quarters · filed 2012-05-04 | ||||
| 2011-06-30 | 37.46M shares 10-Q · filed 2011-08-04 | 34.77M shares 10-Q · filed 2011-08-04 | 33.85M shares derived: average of 3 quarters · filed 2012-05-04 | 33.37M shares derived: average of 4 quarters · filed 2012-05-04 | ||||
| 2011-03-31 | 32.05M shares 10-Q · filed 2012-05-04 | 32.04M shares derived: average of 2 quarters · filed 2012-05-04 | 32.00M shares derived: average of 3 quarters · filed 2012-05-04 | 31.95M shares derived: average of 4 quarters · filed 2012-05-04 | ||||
| 2010-12-31 | 32.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | 31.98M shares derived: average of 2 quarters · filed 2012-03-08 | 31.92M shares derived: average of 3 quarters · filed 2012-03-08 | 31.87M shares 10-K · filed 2012-03-08 | ||||
| 2010-09-30 | 31.92M shares 10-Q · filed 2011-11-03 | 31.87M shares derived: average of 2 quarters · filed 2011-11-03 | 31.81M shares 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | 31.82M shares 10-Q · filed 2011-08-04 | 31.75M shares 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | 19.82M shares 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |